NCT03635034

Brief Summary

Inserting a Bladder catheter during catheter ablation is standard practice at most Institutions. Unfortunately, bladder catheters are associated with adverse outcomes, including catheter associated cystitis, hematuria, dysuria, and urethral damage. The investigator proposes a prospective, randomized clinical trial comparing group A that will receive a catheter during the ablation procedure and group B that will not receive the procedure. The Investigator hypothesizes the group receiving the bladder catheters will have a higher rate of complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 16, 2020

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

2 years

First QC Date

July 27, 2018

Last Update Submit

September 29, 2021

Conditions

Keywords

urinary cathetercatheter ablation procedures

Outcome Measures

Primary Outcomes (1)

  • Composite of catheter associated complications at day one and thirty will be assessed among the two arms - those with bladder catheters and those who did not receive the bladder catheter during the ablation procedure.

    Per patient reported outcomes, subjects will be asked if they experienced any of the following complications: cystitis, hematuria, dysuria, urethral damage and urinary retention. The primary composite outcome of cystitis, hematuria, dysuria, urethral damage or urinary retention will be compared using Chisq or Fisher's exact test. Additional bivariate correlates to the primary outcome will be analysed including age, gender, operator, procedure satisfaction score, procedure duration, procedural fluid administration, total hospital stay fluid administration, and baseline clinical variables. Variables with p value \<o.o5 on bivariate analysis will be included in a multivariate regression model.

    Post-op day 1 and 30 days

Study Arms (2)

No Bladder catheter

EXPERIMENTAL

Subjects will not have bladder catheter inserted during their ablation procedure. Intervention: No catheter

Device: No catheter

Bladder catheter inserted

ACTIVE COMPARATOR

Bladder catheter will be inserted prior to starting ablation procedure after the subject is under general anesthesia. Intervention: bladder catheter inserted

Device: Insert bladder catheter

Interventions

Bladder catheter will be inserted according to randomization schema

Bladder catheter inserted

Subjects will not receive a bladder catheter during the ablation procedure

No Bladder catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects presenting to the St. Vincent EP lab for AF ablation Ability to sign informed consent

You may not qualify if:

  • Recent (within 1 month) cystitis, history of urinary retention or incontinence, prior bladder catheter associated complications, hematuria, chronic kidney disease (stage II, III, IV, or V), dialysis, prostate cancer, renal cancer, bladder cancer, expected procedure duration \>6 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Vincent Hospital and Healthcare Center

Indianapolis, Indiana, 46260, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: We will compare the two groups for complications related to catheter or not having a catheter placed.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2018

First Posted

August 17, 2018

Study Start

January 16, 2018

Primary Completion

January 16, 2020

Study Completion

January 16, 2020

Last Updated

September 30, 2021

Record last verified: 2021-09

Locations